CRS and HIPEC for pancreatic ductal adenocarcinoma with peritoneal metastases: a case report
Background: Pancreatic ductal adenocarcinoma (PDAC) is aggressive, with more than 80% present with metastatic disease, and an overall survival of less than a year with systemic chemotherapy treatment. Cytoreductive surgery (CRS) and intraperitoneal chemotherapy are two treatment modalities being exp...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Surgical Society of North Greece
2023
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/107180/1/CRS%20and%20HIPEC%20for%20pancreatic%20ductal%20adenocarcinoma%20with%20peritoneal%20metastases.pdf http://psasir.upm.edu.my/id/eprint/107180/ https://www.surgchronicles.gr/components/com_journals/journals/2023/4/22.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|